CCL18 and idiopathic interstitial pneumonia: Many biomarkers have been associated with progression and prognosis in IPF and the foremost one is CC chemokine ligand 18 (CCL18), which is a marker of alternatively-activated macrophages (M2 macrophages) with profibrotic mechanisms of action [9,10].